U.S. Physical Therapy, Inc. (NYSE:USPH) Holdings Increased by Bahl & Gaynor Inc.

Bahl & Gaynor Inc. grew its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 95.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 100,315 shares of the company’s stock after buying an additional 49,013 shares during the quarter. Bahl & Gaynor Inc. owned about 0.67% of U.S. Physical Therapy worth $9,343,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Quantbot Technologies LP bought a new stake in shares of U.S. Physical Therapy in the 3rd quarter worth approximately $82,000. Park Avenue Securities LLC purchased a new position in shares of U.S. Physical Therapy in the third quarter worth approximately $232,000. International Assets Investment Management LLC increased its position in shares of U.S. Physical Therapy by 9,269.0% in the fourth quarter. International Assets Investment Management LLC now owns 2,717 shares of the company’s stock worth $253,000 after acquiring an additional 2,688 shares in the last quarter. HighTower Advisors LLC increased its position in shares of U.S. Physical Therapy by 47.2% in the third quarter. HighTower Advisors LLC now owns 2,773 shares of the company’s stock worth $257,000 after acquiring an additional 889 shares in the last quarter. Finally, Channing Capital Management LLC purchased a new position in shares of U.S. Physical Therapy in the third quarter worth approximately $286,000.

Analysts Set New Price Targets

Several research analysts have recently weighed in on USPH shares. Barrington Research lifted their target price on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. JPMorgan Chase & Co. lifted their target price on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. Finally, StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $125.67.

Insider Buying and Selling at U.S. Physical Therapy

In related news, Director Clayton Trier sold 400 shares of the company’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $107.00, for a total value of $42,800.00. Following the completion of the sale, the director now directly owns 7,000 shares in the company, valued at $749,000. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Carey P. Hendrickson sold 1,800 shares of the company’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. Following the completion of the sale, the chief financial officer now directly owns 21,186 shares in the company, valued at $2,272,834.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Clayton Trier sold 400 shares of the company’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $107.00, for a total transaction of $42,800.00. Following the completion of the sale, the director now owns 7,000 shares of the company’s stock, valued at $749,000. The disclosure for this sale can be found here. Insiders sold 10,829 shares of company stock worth $1,141,535 over the last ninety days. 1.80% of the stock is currently owned by insiders.

U.S. Physical Therapy Stock Up 0.3 %

Shares of NYSE:USPH traded up $0.35 during midday trading on Friday, hitting $100.73. 30,485 shares of the stock were exchanged, compared to its average volume of 69,594. The company has a market capitalization of $1.52 billion, a PE ratio of 74.62, a P/E/G ratio of 4.92 and a beta of 1.39. U.S. Physical Therapy, Inc. has a 52-week low of $78.08 and a 52-week high of $124.11. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.28 and a current ratio of 2.28. The business’s fifty day simple moving average is $105.04 and its two-hundred day simple moving average is $95.35.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Wednesday, February 28th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.57 by $0.02. The company had revenue of $154.80 million for the quarter, compared to analyst estimates of $150.24 million. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The business’s revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.58 EPS. As a group, research analysts predict that U.S. Physical Therapy, Inc. will post 2.77 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 5th. Shareholders of record on Tuesday, March 12th were paid a $0.44 dividend. The ex-dividend date was Monday, March 11th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.43. This represents a $1.76 dividend on an annualized basis and a yield of 1.75%. U.S. Physical Therapy’s payout ratio is 130.37%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.